← Back to Discover
Enavate Sciences GP, LLC
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $345,377,333
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- SIONNA THERAPEUTICS INC · COM · 829401108 · shares: $109,008,540
- ZENAS BIOPHARMA INC · COM · 98937L105 · shares: $99,468,255
- IMMUNOME INC · COM · 45257U108 · shares: $76,576,401
- BRIDGEBIO ONCOLOGY THERAPEUT · COM NEW · 107924102 · shares: $20,017,329
- COMPASS THERAPEUTICS INC · COM · 20454B104 · shares: $17,056,049
- UPSTREAM BIO INC · COM · 91678A107 · shares: $17,021,145
- CAMP4 THERAPEUTICS CORP · COM · 13463J101 · shares: $6,229,614
Reported holdings
7 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| SIONNA THERAPEUTICS INC | COM | 829401108 | — | 2,478,030 shares | $109,008,540 |
| ZENAS BIOPHARMA INC | COM | 98937L105 | — | 3,919,159 shares | $99,468,255 |
| IMMUNOME INC | COM | 45257U108 | — | 3,613,799 shares | $76,576,401 |
| BRIDGEBIO ONCOLOGY THERAPEUT | COM NEW | 107924102 | — | 2,626,946 shares | $20,017,329 |
| COMPASS THERAPEUTICS INC | COM | 20454B104 | — | 7,788,150 shares | $17,056,049 |
| UPSTREAM BIO INC | COM | 91678A107 | — | 2,459,703 shares | $17,021,145 |
| CAMP4 THERAPEUTICS CORP | COM | 13463J101 | — | 1,425,541 shares | $6,229,614 |